Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Other financing activities: 2016-2024

Historic Other financing activities for Tg Therapeutics (TGTX) over the last 2 years, with Dec 2024 value amounting to $31,000.

  • Tg Therapeutics' Other financing activities was N/A to $31,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $889,000 for FY2024, which is 611.20% up from last year.
  • According to the latest figures from Q4 2024, Tg Therapeutics' Other financing activities is $31,000, which was down 96.39% from $858,000 recorded in Q3 2024.
  • Tg Therapeutics' Other financing activities' 5-year high stood at $858,000 during Q3 2024, with a 5-year trough of $31,000 in Q4 2024.
  • Its 2-year average for Other financing activities is $338,000, with a median of $125,000 in 2023.